Table 6 KEGG pathways containing target proteins or their interacting partners
Pathway Name | Corrected p-value | Number of target proteins selected | Total number of proteins in pathway | Fraction of population as targets |
|---|---|---|---|---|
MAP kinase signaling pathway | 4.26E-05 | 19 | 259 | 0.073 |
Antigen processing and presentation | 6.66E-05 | 10 | 80 | 0.125 |
Alzheimer's disease | 1.11E-04 | 6 | 28 | 0.214 |
Long-term potentiation | 5.78E-04 | 8 | 65 | 0.123 |
Neurodegenerative disorders | 0.0011 | 6 | 39 | 0.154 |
Long-term depression | 0.0018 | 8 | 75 | 0.107 |
Arginine and proline metabolism | 0.0018 | 7 | 34 | 0.201 |
Adipocytokine signaling pathway | 0.0054 | 7 | 73 | 0.096 |